Pennsylvania-based Rex Medical, LP faces a lawsuit involving the company’s Option IVC filter. Last week a wrongful death lawsuit has been filed by a woman from Florida. The lawsuit was filed on behalf of her deceased husband Deon Desmond Monplaisir who died just 2 weeks after he was implanted with the Option IVC filter made by Rex Medical and Argon Medical Devices. According to the lawsuit the Option™ Retrievable Vena Cava Filter was implanted on September 22, 2014 at a hospital in Tallahassee to prevent pulmonary embolism. Pulmonary embolism is a blockage in one of the pulmonary arteries in your lungs. In most cases, pulmonary embolism is caused by blood clots that travel to the lungs from the legs or, rarely, other parts of the body. Although he was implanted with the filter, on September 29 he suffered a pulmonary embolism and soon after a week on 6th of October he died from respiratory failure and bilateral pulmonary embolism.
The lawsuit of Deon Desmond Monplaisir is represented by Ben C. Martin of the Law Offices of Ben C. Martin in Dallas, Texas. The lawsuit was filed on October 3, 2016 in the Philadelphia Court of Common Pleas under the Case No. 161000070. The Rex Medical and Argon Medical Devices lawsuits allegations are similar allegations to those presented against manufacturers of other IVC filters, including C.R. Bard and Cook Medical. The lawsuits claim that manufacturers failed to warn the general public about the potential health risks associated with the device. The wife of Deon Desmond Monplaisir is pursuing for compensation for the wrongful death of her husband due to the defective device. Rex Medical and Argon Medical Devices accused of concealing known risks, failing to warn about side effects of IVC filter, and continuing to market the filter as safe and effective, despite a lack of studies proving its long-term or short-term safety.
Argon Medical Devices Inc. sells the Option Elite inferior vena cava filter, which was designed by Rex Medical. The filter was approved on 2009 with a 510(k) application, which allowed them to perform only minimal testing before selling the devices for use in patients nationwide. The device is implanted in the inferior vena cava, the largest vein in the body to prevent blood clots that form in the legs and pelvic area from breaking loose and moving to the lungs. Unfortunately, the equivalent devices include two IVC filters made by C.R. Bard. One is the Recovery filer, which was withdrawn in 2005. The other is the G2, which was linked to a 12% five-year fracture risk. As of August 2016 more than 1,300 Bard, Cook and Cordis IVC filter lawsuit have been filed.
Option ELITE is made of nitinol (nickel-titanum alloy), patients who are sensitive to these metals could have allergic reactions. In many instances the filter has malfunctioned and led to serious health problems. For example, pieces of the metal device have broken off and become lodged in the liver, heart, lungs and other major organs. Currently several lawsuits involving these IVC Filter side effects have been filed in the Philadelphia Court of Common Pleas. The IVC filter lawsuits accuses the company of failing to conduct proper medical testing on the Option IVC filter in order to ensure it would work safely once implanted in a patient, as well as failing to follow FDA requirements regarding quality testing. If you or a loved one were implanted with an Option or Option Elite IVC filter, or any other IVC Filter, please contact Drugsclaim.com for free information regarding your legal rights.